Non-melanoma skin cancers or keratinocyte cancers such as basal cell carcinoma and squamous cell carcinoma make up approximately 80% and 20% respectively, of skin cancers with the 6 million people that are treated annually in the United States. 1 in 5 Americans and 2 in 3 Australians develop skin cancer by the age of 70 years and in Australia it is the most expensive, amassing $1.5 billion, to treat cancers. Non-melanoma skin cancers are often self-detected and are usually removed by various means in doctors ’ surgeries. Mohs micrographic surgery is acclaimed to be the gold standard for the treatment of skin cancer. However, a novel microscopic molecular-cellular non-invasive topical therapy described in this article, challenges the status of Mohs procedure for being the acclaimed gold standard.
Kao, S.Y., Ekwueme, D.U., Holman, D.M., Rim, S.H., Thomas, C.C. and Saralya, M. (2022) Economic Burden of Skin Cancer Treatment in the United States: An Analysis of the Medical Expenditure Panel Survey Data, 2012-2018. Cancer Causes & Control, 34, 205-212. https://doi.org/10.1007/s10552-022-01644-0
Cancer Statistics Working Group (2022) U.S. Cancer Statistics Data Vizualisations Tool, Based on 2021 Submission Data (1999-2019): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. https://www.cdc.gov/cancer/dataviz
Cancer Council NSW (2021) Surgery for Skin Cancer.
Patent WO1991010743A1.
Cham, B.E. and Wilson, L. (1987). HPLC of Glycoalkaloids from Solanum sodomaeum L. Planta Medica, 53, 59-61. https://doi.org/10.1055/s-2006-962621
Daunter, B. and Cham, B.E. (1990) Solasodine Glycosides. In Vitro Preferential Cytotoxicity for Human Cancer Cells. Cancer Letters, 55, 209-220. https://doi.org/10.1016/0304-3835(90)90121-D
Cham, B.E. (2013) Drug Therapy: Solamargine and Other Solasodine Rhamnosylglycosides as Anticancer Agents. Modern Chemotherapy, 2, 33-49. https://doi.org/10.4236/mc.2013.22005
Cham, B.E. (1988) Monograph on the Compound BEC. Drugs of the Future, 13, 714-716. https://doi.org/10.1358/dof.1988.013.08.63026
Millward, M., Powell, A., Daly, P., Tyson, R., Ferguson, R. and Carter, S. (2006) Results of Phase I Clinical Trials of Coramsine in Patients with Advanced Solid Tumours. Journal Clinical Oncology, 24, 2070. https://doi.org/10.1200/jco.2006.24.18_suppl.2070
Millward, M., Powell, A., Tyson, S., Daly, P., Ferguson, R. and Carter, S. (2005) Phase I Trial of Coramsine (SBP002) in Patients with Advanced Solid Tumours. Journal Clinical Oncology, 23, 3105. https://doi.org/10.1200/jco.2005.23.16_suppl.3105
Cham, A., Cham, K., Chase, T. and Cham, B. (2015) A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5. Journal Cancer Treatment and Research, 3, 22-27. https://doi.org/10.11648/j.jctr.20150302.12
Cham, B.E. and Daunter, B. (1990) Solasodine Glycosides. Selective Cytotoxicity for Cancer Cells and Inhibition of Cytotoxicity by Rhamnose in Mice with Sarcoma 180. Cancer Letters, 55, 221-225. https://doi.org/10.1016/0304-3835(90)90122-E
Cham, B.E. (2007) Solasodine Rhamnosyl Glycosides Specifically Bind Cancer Cell Receptors and Induce Apoptosis and Necrosis. Treatment for Skin Cancer and Hope for Internal Cancers. Research Journal of Biological Sciences, 2, 503-514.
Cham, B.E. (1994) Solasodine Glycosides as Anticancer Agents: Preclinical and Clinical Studies. Asia Pacific Journal of Pharmacology, 9, 113-118.
Li, X., Zhao, Y., Wu, W.K., Liu, S., Cui, M. and Lou, H. (2011) Solamargine Induces Apoptosis with p53 Transcription-Dependent and Transcription-Independent Pathways in Human Osteosarcoma U2OS Cells. Life Sciences, 88, 314-321. https://doi.org/10.1016/j.lfs.2010.12.006
Al Sinani, S.S., Eltayeb, E.A., Coomber, B.L. and Adham, S.A. (2016) Solamarginetriggers Cellular Necrosis Selectively in Different Types of Human Melanoma Cancercells through Extrinsic Lysosomal Mitochondrial Death Pathways. Cancer Cell International, 16, Article No. 11. https://doi.org/10.1186/s12935-016-0287-4
Zang, X., Yan, Z., Xu, T., An, Z., Chen, W., Wang, X., Huang, M. and Zhu, F. (2018) SM Derived from Solanum nigrum Induces Apoptosis of Human Cholangio Carcinoma QBC939 Cells. Oncology Letters, 15, 6329-6335. https://doi.org/10.3892/ol.2018.8171
Al Sinani, S.S.S. and Eltayeb, E.A. (2017) The Steroidal Glycoalkaloids Solamargineand Solasonine in Solanum Plants. South African Journal of Botany, 112, 253-269. https://doi.org/10.1016/j.sajb.2017.06.002
Kalalinia, F. and Korimi-Sani, I. (2017) Anticancer Properties of Solamargine: A Systematic Review. Phytotherapy Research, 31, 858-870.
Sani, I.K., Marashi, S.H. and Kalalinia, F. (2015) Solamargine Inhibits Migrationand Invasion of Human Hepatocellular Carcinoma Cells through Down-Regulation of Matrix Metalloproteinases 2 and 9 Expression and Activity. Toxicology in Vitro, 29, 893-900. https://doi.org/10.1016/j.tiv.2015.03.012
Li, X., Zhao, Y., Liu, S., Cui, M. and Lou, H. (2011) Induction of Actin Disruptionand Downregulation of P-Glycoprotein Expression of Solamargine in Multidrug-Resistant K562/A02 Cells. Chinese Medical Journal, 124, 2038-2044.
Cham, B.E. and Meares, H.M. (1987) Glycoalkaloids from Solanum Sodomaeum Are Effective in the Treatment of Skin Cancers in Man. Cancer Letters, 36, 111-118. https://doi.org/10.1016/0304-3835(87)90081-4
Cham, B.E., Daunter, B. and Evans, R. (1991) Topical Treatment of Malignant and Premalignant Skin Lesions by Very Low Concentrations of a Standard Mixture (BEC) of Solasodine Glycosides. Cancer Letters, 59, 183-192. https://doi.org/10.1016/0304-3835(91)90140-D
Cham, B.E. (2022) The Pharmacology of Curaderm in the Treatment of Basal CellCarcinoma. Clinical Medical Review and Case Reports, 9, Article 399. https://doi.org/10.23937/2378-3656/1410399
Chase, T.R., Cham, K.E. and Cham, B.E. (2024) The Value of Excipients and the Required Understanding of the Biological System in Product Development: An Impactful Example of Curaderm, a Topical Skin Cancer Treatment. International Journal of Clinical Medicine, 15, 68-87 https://doi.org/10.4236/ijcm.2024.152005
Punjabi, S., Cook, L.J., Kersey, P., Marks, R. and Cerio, R. (2008) Solasodine Glycoalkaloids: A Novel Topical Therapy for Basal Cell Carcinoma. A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicentre Study. International Journal of Dermatology, 47, 78-82. https://doi.org/10.1111/j.1365-4632.2007.03363.x
Cham, B.E. (2013) Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with CuradermBEC5. Journal of Cancer Therapy, 4, 588-596. https://doi.org/10.4236/jct.2013.42076
Cham, B.E., Gilliver, M. and Wilson, L. (1987) Antitumour Effects of Glycoalkaloids Isolated from Solanum sodomaeum L. Planta Medica, 53, 34-36. https://doi.org/10.1055/s-2006-962612
Cham, B.E. (2023) Holistic Approach in the Treatment of Actinic Keratosis: Benefits and Disadvantages of 5-Fluorouracil, Imiquimod, Diclofenac and Curaderm. International Journal of Clinical Medicine, 14, 319-331. https://doi.org/10.4236/ijcm.2023.147027
Dobrokhotova, F.Z., Betzev, A.E. and Belysheva, T.S. (2016) The Use of Kuraderm Drug in the Treatment of Basal Cell Carcinoma of the Head and Neck. Head and Neck Tumors, 6, 22-26. https://doi.org/10.17650/2222-1468-2016-6-3-22-26
Batsev, A.E., Dobrokhotova, V.Z. and Cham, B.E. (2016) Topical Cream Curadermbec5 Treats a Recalcitrant Basal Cell Carcinoma. Clinical Medical Reviews and Case Reports, 3, Article ID: 098. https://doi.org/10.23937/2378-3656/1410098
Chase, T., Cham, K.E. and Cham, B.E. (2020) Curaderm, the Long-Awaited Breakthrough for Basal Cell Carcinoma. International Journal of Clinical Medicine, 11, 579-604. https://doi.org/10.4236/ijcm.2020.1110050
Cham, B.E. (2014) A Review of Solasodine Rhamnosides Therapy for in-Situ Squamous Cell Carcinoma of the Penis. British Journal of Medicine and Medical Research, 4, 621-631. https://doi.org/10.9734/BJMMR/2014/4677
Goldberg, L.H., Landau, J.M., Moody, M.N. and Vergilis-Kalner, I. (2011) Treatment of Bowen’s Disease on the Penis with Low Concentrations of a Standard Mixture of Solasodine Glycosides and Liquid Nitrogen. Dermatologic Surgery, 37, 858-861. https://doi.org/10.1111/j.1524-4725.2011.02014.x
Yu, S., Sheu, H.M. and Lee, C.H. (2017) Solanum incanum Extract (SR-T100) Induces Melanoma Cell Apoptosis and Inhibits Established Lung Metastasis: A Case Report. Oncotarget, 8, 103509-103517. https://doi.org/10.18632/oncotarget.21508
Cham, B.E. (2020) First in Man Topical Treatment of Melanoma with Solasodine Glycosides in a Formulation Curaderm. Journal of Cancer Therapy, 11, 617-630. https://doi.org/10.4236/jct.2020.1110052
Wang, Y., Gao, J., Gu, G., Li, G., Cui, C., et al. (2011) In Situ RBL Receptor Visualization and Its Mediated Anticancer Activity for Solasodine Rhamnosides. ChemBioChem, 12, 2418-2420. https://doi.org/10.1002/cbic.201100551
Kokkinos, C., Kanapathy, M., Heydari, S., Hamilton, S. and Withey, S. (2022) Waiting Time for Mohs Micrographic Surgery and the Associated Increase in Lesion Size of Basal Cell Carcinoma. Journal of Plastic, Reconstructive & Aesthetic Surgery, 75, 3384-3389. https://doi.org/10.1016/j.bjps.2022.05.001